Skip to main content

Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway

Retraction to: Cancer Cell Int (2018) 18:176 https://doi.org/10.1186/s12935-018-0671-3

The editor has retracted this article [1] because Figures 2 and 4 contain duplicated and modified figures from [2,3,4]. The data reported in this article are therefore unreliable.

  • Figure 2m in [1] contains figures that have been duplicated and modified from Fig. 2a in [2].

  • Figure 2 m in [1] contains figures that have been duplicated and modified from Fig. 6j in [3].

  • Figure 4g in [1] is identical to Fig. 4f in [4].

  • Figure 4i in [1] contains figures that are identical to Fig. 4h in [4].

None of the authors have responded to any correspondence from the editor/publisher about this retraction.

References

  1. 1.

    Ding X, Sun W, Chen J. IL-2 augments the sorafenib-induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway. Cancer Cell Int. 2018;18:176. https://doi.org/10.1186/s12935-018-0671-3.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Wei R, Cao J, Yao S. Matrine promotes liver cancer cell apoptosis by inhibiting mitophagy and PINK1/Parkin pathways. Cell Stress Chaperones. 2018;23:1295. https://doi.org/10.1007/s12192-018-0937-7.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Jieensinue S, Zhu H, Li G, et al. Tanshinone IIA reduces SW837 colorectal cancer cell viability via the promotion of mitochondrial fission by activating JNK-Mff signaling pathways. BMC Cell Biol. 2018;19:21. https://doi.org/10.1186/s12860-018-0174-z.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Zhang L, Li S, Wang R, Chen C, Ma W, Cai H. Cytokine augments the sorafenib-induced apoptosis in Huh7 liver cancer cell by inducing mitochondrial fragmentation and activating MAPK-JNK signalling pathway. Biomed Pharmacother. 2019;110:213–23. https://doi.org/10.1016/j.biopha.2018.11.037.

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Jinglong Chen.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ding, X., Sun, W. & Chen, J. Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway. Cancer Cell Int 19, 358 (2019). https://doi.org/10.1186/s12935-019-1083-8

Download citation